GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.57e-05 | 2.27e-01 | 8.308 | 2 | 2 | 13 |
GO:0044212 | transcription regulatory region DNA binding | 5.25e-05 | 7.57e-01 | 5.201 | 3 | 17 | 168 |
GO:0051059 | NF-kappaB binding | 6.03e-05 | 8.69e-01 | 7.365 | 2 | 3 | 25 |
GO:0008134 | transcription factor binding | 1.55e-04 | 1.00e+00 | 4.675 | 3 | 18 | 242 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0060177 | regulation of angiotensin metabolic process | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:1901985 | positive regulation of protein acetylation | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0043969 | histone H2B acetylation | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:2000629 | negative regulation of miRNA metabolic process | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0006355 | regulation of transcription, DNA-templated | 6.71e-04 | 1.00e+00 | 3.047 | 4 | 43 | 997 |
GO:0005654 | nucleoplasm | 9.17e-04 | 1.00e+00 | 2.929 | 4 | 64 | 1082 |
GO:0060242 | contact inhibition | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0014737 | positive regulation of muscle atrophy | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:2000483 | negative regulation of interleukin-8 secretion | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0090043 | regulation of tubulin deacetylation | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 2 | 2 |
GO:0035984 | cellular response to trichostatin A | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0071389 | cellular response to mineralocorticoid stimulus | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0043503 | skeletal muscle fiber adaptation | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0010560 | positive regulation of glycoprotein biosynthetic process | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0097157 | pre-mRNA intronic binding | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0009991 | response to extracellular stimulus | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0006974 | cellular response to DNA damage stimulus | 2.21e-03 | 1.00e+00 | 4.770 | 2 | 7 | 151 |
GO:0005829 | cytosol | 2.38e-03 | 1.00e+00 | 2.045 | 5 | 86 | 2496 |
GO:0001714 | endodermal cell fate specification | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0030240 | skeletal muscle thin filament assembly | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0065004 | protein-DNA complex assembly | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0060298 | positive regulation of sarcomere organization | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0032025 | response to cobalt ion | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0004859 | phospholipase inhibitor activity | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0005865 | striated muscle thin filament | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0005667 | transcription factor complex | 2.95e-03 | 1.00e+00 | 4.558 | 2 | 17 | 175 |
GO:0003714 | transcription corepressor activity | 3.05e-03 | 1.00e+00 | 4.533 | 2 | 11 | 178 |
GO:0006475 | internal protein amino acid acetylation | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.43e-03 | 1.00e+00 | 3.145 | 3 | 39 | 699 |
GO:0001955 | blood vessel maturation | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0005869 | dynactin complex | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0060765 | regulation of androgen receptor signaling pathway | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 9 |
GO:0035259 | glucocorticoid receptor binding | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 9 |
GO:0045793 | positive regulation of cell size | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 2 | 9 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.83e-03 | 1.00e+00 | 2.970 | 3 | 41 | 789 |
GO:0035413 | positive regulation of catenin import into nucleus | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0016407 | acetyltransferase activity | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0010226 | response to lithium ion | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0043923 | positive regulation by host of viral transcription | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 3 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 3 | 11 |
GO:0042975 | peroxisome proliferator activated receptor binding | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 4 | 11 |
GO:0003713 | transcription coactivator activity | 5.35e-03 | 1.00e+00 | 4.120 | 2 | 24 | 237 |
GO:0035198 | miRNA binding | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0048545 | response to steroid hormone | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 13 |
GO:0071480 | cellular response to gamma radiation | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 13 |
GO:0051019 | mitogen-activated protein kinase binding | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 13 |
GO:0016746 | transferase activity, transferring acyl groups | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 13 |
GO:0070542 | response to fatty acid | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 14 |
GO:0032993 | protein-DNA complex | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 2 | 14 |
GO:0001824 | blastocyst development | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 2 | 15 |
GO:1990090 | cellular response to nerve growth factor stimulus | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 15 |
GO:0048741 | skeletal muscle fiber development | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 2 | 17 |
GO:0012506 | vesicle membrane | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 17 |
GO:0045773 | positive regulation of axon extension | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 18 |
GO:0033613 | activating transcription factor binding | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 3 | 18 |
GO:0035257 | nuclear hormone receptor binding | 9.19e-03 | 1.00e+00 | 6.761 | 1 | 1 | 19 |
GO:0071549 | cellular response to dexamethasone stimulus | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 3 | 20 |
GO:0010942 | positive regulation of cell death | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 20 |
GO:0032757 | positive regulation of interleukin-8 production | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 20 |
GO:0000123 | histone acetyltransferase complex | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 6 | 21 |
GO:0032967 | positive regulation of collagen biosynthetic process | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 3 | 21 |
GO:0045862 | positive regulation of proteolysis | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 2 | 21 |
GO:0003823 | antigen binding | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 2 | 22 |
GO:0043565 | sequence-specific DNA binding | 1.11e-02 | 1.00e+00 | 3.574 | 2 | 11 | 346 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 23 |
GO:0043388 | positive regulation of DNA binding | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 2 | 24 |
GO:0043425 | bHLH transcription factor binding | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 24 |
GO:0035329 | hippo signaling | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 26 |
GO:0048565 | digestive tract development | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 26 |
GO:0034612 | response to tumor necrosis factor | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 2 | 27 |
GO:0043967 | histone H4 acetylation | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 27 |
GO:0043531 | ADP binding | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 3 | 28 |
GO:0050714 | positive regulation of protein secretion | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 3 | 28 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 30 |
GO:0005544 | calcium-dependent phospholipid binding | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 30 |
GO:0042594 | response to starvation | 1.50e-02 | 1.00e+00 | 6.055 | 1 | 4 | 31 |
GO:0043491 | protein kinase B signaling | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 2 | 32 |
GO:0005737 | cytoplasm | 1.56e-02 | 1.00e+00 | 1.451 | 5 | 124 | 3767 |
GO:0071333 | cellular response to glucose stimulus | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 33 |
GO:0001756 | somitogenesis | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 33 |
GO:0003677 | DNA binding | 1.62e-02 | 1.00e+00 | 2.343 | 3 | 49 | 1218 |
GO:0030017 | sarcomere | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 2 | 34 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 36 |
GO:0030049 | muscle filament sliding | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 3 | 38 |
GO:0032092 | positive regulation of protein binding | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 2 | 38 |
GO:0031490 | chromatin DNA binding | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 2 | 38 |
GO:0050681 | androgen receptor binding | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 1 | 38 |
GO:0035019 | somatic stem cell maintenance | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 6 | 40 |
GO:0007519 | skeletal muscle tissue development | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 2 | 40 |
GO:0046332 | SMAD binding | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 2 | 40 |
GO:0071320 | cellular response to cAMP | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 1 | 40 |
GO:0070301 | cellular response to hydrogen peroxide | 1.97e-02 | 1.00e+00 | 5.651 | 1 | 2 | 41 |
GO:0004402 | histone acetyltransferase activity | 2.07e-02 | 1.00e+00 | 5.582 | 1 | 6 | 43 |
GO:0045727 | positive regulation of translation | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 44 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 4 | 44 |
GO:0005884 | actin filament | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 3 | 44 |
GO:0043966 | histone H3 acetylation | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 5 | 45 |
GO:0001047 | core promoter binding | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 5 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 4 | 46 |
GO:0016049 | cell growth | 2.35e-02 | 1.00e+00 | 5.394 | 1 | 3 | 49 |
GO:0035690 | cellular response to drug | 2.35e-02 | 1.00e+00 | 5.394 | 1 | 3 | 49 |
GO:0005515 | protein binding | 2.38e-02 | 1.00e+00 | 1.037 | 6 | 198 | 6024 |
GO:0006986 | response to unfolded protein | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 4 | 50 |
GO:0009612 | response to mechanical stimulus | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 2.45e-02 | 1.00e+00 | 5.336 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 2.45e-02 | 1.00e+00 | 5.336 | 1 | 1 | 51 |
GO:0009611 | response to wounding | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 5 | 52 |
GO:0007623 | circadian rhythm | 2.54e-02 | 1.00e+00 | 5.281 | 1 | 1 | 53 |
GO:0001725 | stress fiber | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 4 | 55 |
GO:0071300 | cellular response to retinoic acid | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 1 | 55 |
GO:0051592 | response to calcium ion | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 1 | 55 |
GO:0002039 | p53 binding | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 4 | 55 |
GO:0048306 | calcium-dependent protein binding | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 2 | 56 |
GO:0043627 | response to estrogen | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 5 | 56 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 2.83e-02 | 1.00e+00 | 5.126 | 1 | 6 | 59 |
GO:0008013 | beta-catenin binding | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 9 | 60 |
GO:0032481 | positive regulation of type I interferon production | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 6 | 61 |
GO:0030855 | epithelial cell differentiation | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 1 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 2 | 61 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 3.02e-02 | 1.00e+00 | 5.031 | 1 | 3 | 63 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 3.02e-02 | 1.00e+00 | 5.031 | 1 | 4 | 63 |
GO:0010468 | regulation of gene expression | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 2 | 68 |
GO:0043086 | negative regulation of catalytic activity | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 2 | 72 |
GO:0030324 | lung development | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 1 | 72 |
GO:0000785 | chromatin | 3.49e-02 | 1.00e+00 | 4.819 | 1 | 6 | 73 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 4 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 75 |
GO:0005634 | nucleus | 3.60e-02 | 1.00e+00 | 1.176 | 5 | 159 | 4559 |
GO:0001889 | liver development | 3.68e-02 | 1.00e+00 | 4.742 | 1 | 3 | 77 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 3.77e-02 | 1.00e+00 | 4.705 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 3.96e-02 | 1.00e+00 | 4.634 | 1 | 2 | 83 |
GO:0009887 | organ morphogenesis | 4.10e-02 | 1.00e+00 | 4.582 | 1 | 5 | 86 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 4.10e-02 | 1.00e+00 | 4.582 | 1 | 8 | 86 |
GO:0045471 | response to ethanol | 4.10e-02 | 1.00e+00 | 4.582 | 1 | 3 | 86 |
GO:0006936 | muscle contraction | 4.15e-02 | 1.00e+00 | 4.566 | 1 | 3 | 87 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 1 | 90 |
GO:0005200 | structural constituent of cytoskeleton | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 6 | 91 |
GO:0071456 | cellular response to hypoxia | 4.38e-02 | 1.00e+00 | 4.485 | 1 | 3 | 92 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 4.38e-02 | 1.00e+00 | 4.485 | 1 | 7 | 92 |
GO:0005770 | late endosome | 4.43e-02 | 1.00e+00 | 4.470 | 1 | 2 | 93 |
GO:0051726 | regulation of cell cycle | 4.61e-02 | 1.00e+00 | 4.409 | 1 | 5 | 97 |
GO:0001934 | positive regulation of protein phosphorylation | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 5 | 104 |
GO:0072562 | blood microparticle | 5.27e-02 | 1.00e+00 | 4.214 | 1 | 3 | 111 |
GO:0006325 | chromatin organization | 5.59e-02 | 1.00e+00 | 4.126 | 1 | 12 | 118 |
GO:0007219 | Notch signaling pathway | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 5 | 120 |
GO:0007050 | cell cycle arrest | 5.87e-02 | 1.00e+00 | 4.055 | 1 | 5 | 124 |
GO:0000086 | G2/M transition of mitotic cell cycle | 6.42e-02 | 1.00e+00 | 3.921 | 1 | 4 | 136 |
GO:0016055 | Wnt signaling pathway | 6.51e-02 | 1.00e+00 | 3.900 | 1 | 4 | 138 |
GO:0007507 | heart development | 6.56e-02 | 1.00e+00 | 3.890 | 1 | 7 | 139 |
GO:0001666 | response to hypoxia | 7.01e-02 | 1.00e+00 | 3.790 | 1 | 7 | 149 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 7.74e-02 | 1.00e+00 | 3.642 | 1 | 12 | 165 |
GO:0031965 | nuclear membrane | 7.88e-02 | 1.00e+00 | 3.616 | 1 | 10 | 168 |
GO:0015629 | actin cytoskeleton | 8.28e-02 | 1.00e+00 | 3.541 | 1 | 5 | 177 |
GO:0031625 | ubiquitin protein ligase binding | 8.33e-02 | 1.00e+00 | 3.533 | 1 | 5 | 178 |
GO:0032403 | protein complex binding | 8.55e-02 | 1.00e+00 | 3.493 | 1 | 6 | 183 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 8.60e-02 | 1.00e+00 | 3.485 | 1 | 22 | 184 |
GO:0070062 | extracellular vesicular exosome | 9.54e-02 | 1.00e+00 | 1.365 | 3 | 57 | 2400 |
GO:0007399 | nervous system development | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 6 | 231 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.21e-01 | 1.00e+00 | 2.964 | 1 | 23 | 264 |
GO:0005524 | ATP binding | 1.25e-01 | 1.00e+00 | 1.667 | 2 | 31 | 1298 |
GO:0003682 | chromatin binding | 1.48e-01 | 1.00e+00 | 2.656 | 1 | 19 | 327 |
GO:0005813 | centrosome | 1.48e-01 | 1.00e+00 | 2.660 | 1 | 7 | 326 |
GO:0008283 | cell proliferation | 1.49e-01 | 1.00e+00 | 2.651 | 1 | 14 | 328 |
GO:0046982 | protein heterodimerization activity | 1.71e-01 | 1.00e+00 | 2.439 | 1 | 8 | 380 |
GO:0000278 | mitotic cell cycle | 1.75e-01 | 1.00e+00 | 2.398 | 1 | 15 | 391 |
GO:0009986 | cell surface | 1.80e-01 | 1.00e+00 | 2.358 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.84e-01 | 1.00e+00 | 2.319 | 1 | 24 | 413 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.87e-01 | 1.00e+00 | 2.298 | 1 | 30 | 419 |
GO:0043066 | negative regulation of apoptotic process | 1.89e-01 | 1.00e+00 | 2.281 | 1 | 16 | 424 |
GO:0044267 | cellular protein metabolic process | 2.09e-01 | 1.00e+00 | 2.120 | 1 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.10e-01 | 1.00e+00 | 2.108 | 1 | 24 | 478 |
GO:0042802 | identical protein binding | 2.13e-01 | 1.00e+00 | 2.090 | 1 | 19 | 484 |
GO:0048471 | perinuclear region of cytoplasm | 2.20e-01 | 1.00e+00 | 2.037 | 1 | 8 | 502 |
GO:0005509 | calcium ion binding | 2.31e-01 | 1.00e+00 | 1.956 | 1 | 11 | 531 |
GO:0016032 | viral process | 2.32e-01 | 1.00e+00 | 1.948 | 1 | 26 | 534 |
GO:0006915 | apoptotic process | 2.40e-01 | 1.00e+00 | 1.892 | 1 | 12 | 555 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.46e-01 | 1.00e+00 | 1.854 | 1 | 37 | 570 |
GO:0045087 | innate immune response | 2.56e-01 | 1.00e+00 | 1.790 | 1 | 15 | 596 |
GO:0010467 | gene expression | 2.83e-01 | 1.00e+00 | 1.623 | 1 | 45 | 669 |
GO:0007165 | signal transduction | 3.65e-01 | 1.00e+00 | 1.184 | 1 | 13 | 907 |
GO:0005615 | extracellular space | 3.82e-01 | 1.00e+00 | 1.106 | 1 | 20 | 957 |
GO:0008270 | zinc ion binding | 3.94e-01 | 1.00e+00 | 1.047 | 1 | 27 | 997 |
GO:0044822 | poly(A) RNA binding | 4.13e-01 | 1.00e+00 | 0.964 | 1 | 50 | 1056 |
GO:0006351 | transcription, DNA-templated | 5.23e-01 | 1.00e+00 | 0.511 | 1 | 57 | 1446 |
GO:0005730 | nucleolus | 5.71e-01 | 1.00e+00 | 0.328 | 1 | 66 | 1641 |
GO:0016020 | membrane | 5.80e-01 | 1.00e+00 | 0.294 | 1 | 46 | 1681 |
GO:0005886 | plasma membrane | 7.49e-01 | 1.00e+00 | -0.326 | 1 | 49 | 2582 |